DiscGenics
Blood & Organ Banks · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5940 W Harold Gatty Dr, Salt Lake City, ...Phone Number
(801) 410-0703Website
www.discgenics.comRevenue
$6.2 MillionIndustry
ZI Rank: 4
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
3
4
4
3
4
About DiscGenics
DiscGenics is dedicated to developing innovative regenerative therapies aimed at alleviating pain and restoring function for patients suffering from degenerative diseases of the spine. Their primary product candidate, IDCT, is an allogeneic, injectable cell therapy designed to treat mild to moderate lumbar disc degeneration. The company focuses on engineering specialized therapeutic progenitor cells, known as Discogenic Cells, to address the complexities of degenerated discs. DiscGenics aims to revolutionize the treatment of chronic back pain for millions of patients.Explore more
DiscGenics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DiscGenics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if DiscGenics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at DiscGenics
Product Launch: Get notified when DiscGenics launches new products
Check out if DiscGenics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on DiscGenics recently announced quarterly report
Click to see if DiscGenics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
DiscGenics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once DiscGenics has new funding data
Recommended Actions
Find VP level buyers at DiscGenics
Find 3 more new buyers
Compare Similar Companies to DiscGenics
Compare insights from companies similar to DiscGenics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DiscGenics
$6.2M
11-50
Private
$71.9M
2007
RW
Robert WynalekChief Operating Officer & Chief Commercialization Officer
Company Profile Activity
Activity Insights
DiscGenics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
DiscGenics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about DiscGenics.
DiscGenics financials insights
Gather financial insights about DiscGenics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$7M
2017
Series B
$14M
2020
Debt
$350K
Series C
$50M
2021
Debt
$562K
DiscGenics Tech Stack
A closer look at the technologies used by DiscGenics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
, according to a front-line source in product development, is in the midst of initiatives related to quality assurance. The organization is currently evaluating ETQ Reliance.
Quality Assurance, Product Development, Product Management
Award
Award
Project
A mid-level source in Facilities Management has indicated that the organization is in the midst of initiatives related to enterprise resource planning (ERP) software. The organization is rolling out integrated modules through NetSuite to support these efforts.
Business Development, Enterprise Software, Operating Systems, Software, Facilities Management
Project
Business Intelligence, Analytics & Insights, Facilities Management
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DiscGenics
Sign Up For FreeTo access detailed company insights
DiscGenics is dedicated to developing innovative regenerative therapies aimed at alleviating pain and restoring function for patients suffering from degenerative diseases of the spine. Their primary product candidate, IDCT, is an allogeneic, injectable cell therapy designed to treat mild to moderate lumbar disc degeneration. The company focuses on... Read More
